Novavax Inc

Novavax Inc. a biotechnology company that promotes improved health by discovering developing and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges which is evaluating vaccines for COVID-19 influenza and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine NVX-CoV2373 under the brand names of Nuvaxovid Covovax and Novavax COVID-19 Vaccine Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax Inc. was incorporated in 1987 and is headquartered in Gaithersburg Maryland.